A clinical study to check the effect of Brahmi ghrita on symptoms of Autism in children and In vivo study to check the effect of Brahmi ghrita in serum levels of Dopamine and GABA in rat models.

A study to evaluate the efficacy of Brahmi ghrita in modulating Dopamine and GABA Levels on Rat Models of Autism and its clinical efficacy in children with Autism: A Preclinical and Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098613

Enrollment

Registered

2025-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Those meeting DSM five TR and AIIMS modified INCLEN criteria ISAA score more than 70

Exclusion criteria

Exclusion criteria: One who does not meet DSM five TR and AIIMS modified INCLEN criteria Children having any other psychotic or neurological disorder Children having any co-morbid conditions or congenital disorder or genetic syndromes

Design outcomes

Primary

Measure	Time frame
Changes in plasma level of Dopamine and GABA in experimental rats Changes in CARS 2 score Changes in ISAA score Timepoint: baseline 4th week 8th week 12th week	—

Secondary

Measure	Time frame
Changes in Symptoms of ASD as per Ayurveda perspectivesTimepoint: baseline 4th week 8th week 12th week	—

Countries

India

Contacts

Public ContactNeha

National Institute of Ayurveda

drnishaojha@gmail.com8890072697

Outcome results